Cargando…

Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021

BACKGROUND: In Japan, a part of confirmed patients’ samples have been screened for the variant of concern (VOC), including the variant alpha with N501Y mutation. The present study aimed to estimate the actual number of cases with variant alpha and reconstruct the epidemiological dynamics. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murayama, Hiroaki, Kayano, Taishi, Nishiura, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286039/ https://www.ncbi.nlm.nih.gov/pubmed/34273991 http://dx.doi.org/10.1186/s12976-021-00146-x

Ejemplares similares

VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy
por: Rondinone, Valeria, et al.
Publicado: (2021)

Dying of VOC-202012/01 — multimodal investigations in a death case of the SARS-CoV-2 variant
por: Heinrich, Fabian, et al.
Publicado: (2021)

Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
por: Kayano, Taishi, et al.
Publicado: (2023)

Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)
por: Loconsole, Daniela, et al.
Publicado: (2021)

Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru
por: Padilla-Rojas, C., et al.
Publicado: (2021)

Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain
por: Rabie, Amgad M.
Publicado: (2021)

Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012–01) in England
por: Chudasama, Dimple Y., et al.
Publicado: (2021)

Evaluation of the Diagnostic Value of Hematologic Parameters and Ratios in SARS-CoV-2 VOC-202012/01 Mutant Population
por: Seyit, Murat, et al.
Publicado: (2022)

Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
por: Jung, Sung-mok, et al.
Publicado: (2022)

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
por: Gaymard, Alexandre, et al.
Publicado: (2021)

Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy
por: Loconsole, Daniela, et al.
Publicado: (2021)

Age-Dependent Risks of COVID-19 Putatively Caused by Variant Alpha in Japan
por: Kayano, Taishi, et al.
Publicado: (2022)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
por: Giovacchini, Nicla, et al.
Publicado: (2021)

Estimating the Force of Infection with Helicobacter pylori in Japan
por: Kayano, Taishi, et al.
Publicado: (2019)

Assessing Public Health and Social Measures Against COVID-19 in Japan From March to June 2021
por: Hayashi, Katsuma, et al.
Publicado: (2022)

Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods
por: English, Emma, et al.
Publicado: (2021)

New COVID-19 Variant, VUI-202012/01: Molecular Change, Epitope Alteration, and Implication for Vaccine Efficacy
por: Joob, Beuy, et al.
Publicado: (2021)

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
por: Ito, Kimihito, et al.
Publicado: (2021)

Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number
por: Kayano, Taishi, et al.
Publicado: (2023)

Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan
por: Ko, Yura K., et al.
Publicado: (2022)

A Comparison of Case Fatality Risk of COVID-19 between Singapore and Japan
por: Kayano, Taishi, et al.
Publicado: (2020)

CRD Editor’s Corner Archive: January–March 2021
por: Steiner, Michael C
Publicado: (2021)

SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
por: Grabowski, Frederic, et al.
Publicado: (2021)

Controlling healthcare-associated transmission of SARS-CoV-2 variant of concern 202012/01 in a large hospital network
por: Duverger, C., et al.
Publicado: (2021)

SARS-CoV-2 Variants, South Sudan, January–March 2021
por: Bugembe, Daniel Lule, et al.
Publicado: (2021)

Assessing dengue control in Tokyo, 2014
por: Yuan, Baoyin, et al.
Publicado: (2019)

Modelling a Supplementary Vaccination Program of Rubella Using the 2012–2013 Epidemic Data in Japan
por: Kayano, Taishi, et al.
Publicado: (2019)

Monitoring the COVID-19 immune landscape in Japan
por: Sasanami, Misaki, et al.
Publicado: (2022)

SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021
por: Fu, Jolene Yin Ling, et al.
Publicado: (2022)

Progress Toward Poliomyelitis Eradication — Worldwide, January 2021–March 2023
por: Lee, Scarlett E., et al.
Publicado: (2023)

371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January–March 2021
por: Graciaa, Daniel, et al.
Publicado: (2021)

January-March 2009
Publicado: (2009)

January-March 2008
Publicado: (2008)

January-March 2007
Publicado: (2007)

January-March 1997
Publicado: (1997)

January-March 1998
Publicado: (1998)

January-March 1999
Publicado: (1999)

January-March 2001
Publicado: (2001)

January-March 2002
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_q8d7r2vrrjc0me7084j8rsgigv